{"resourceType":"Bundle","id":"tests-18139ed5-7f67-428b-a7b6-776f34c70f5d-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d","resource":{"resourceType":"Patient","id":"18139ed5-7f67-428b-a7b6-776f34c70f5d","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2028-9","display":"Asian","userSelected":true}},{"url":"text","valueString":"Asian"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2186-5","display":"Not Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Not Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd0bb085b0356a7c28532d"}],"name":[{"family":"DenomFail","given":["FirstTxEndsBeforeMP"]}],"gender":"male","birthDate":"1979-12-31"},"request":{"method":"PUT","url":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"80c36722-e2f9-4c3c-a182-c665cde7c05d","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"},{"system":"http://snomed.info/sct","code":"439401001","display":"Diagnosis"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"onsetPeriod":{"start":"2020-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/80c36722-e2f9-4c3c-a182-c665cde7c05d"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"9fcde056-8c9b-4c97-ac7d-7cabde73ad07","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2023-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"performedDateTime":"2021-12-31T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/9fcde056-8c9b-4c97-ac7d-7cabde73ad07"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8da","resource":{"resourceType":"Observation","id":"e4937dbb-7f0a-4fb1-810a-ab191f5a3732","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"issued":"2025-04-22T08:00:00.000+00:00","valueQuantity":{"value":11.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/e4937dbb-7f0a-4fb1-810a-ab191f5a3732"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"0e43d5fc-6c06-42c4-baec-0c992a3d436b","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"effectiveDateTime":"2025-01-02T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/0e43d5fc-6c06-42c4-baec-0c992a3d436b"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"c5274e45-e08e-400d-909a-83da00a32dca","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"effectiveDateTime":"2025-04-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"Neoplasm of prostate primary tumor staging category T2a: Involves one-half of one lobe or less (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/c5274e45-e08e-400d-909a-83da00a32dca"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"6c6d0349-48fd-40be-9e5f-0718cdf11849","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/18139ed5-7f67-428b-a7b6-776f34c70f5d"},"payor":[{"reference":"Organization/f6075515-d38f-4624-bde8-a1ce20473a69"}]},"request":{"method":"PUT","url":"Coverage/6c6d0349-48fd-40be-9e5f-0718cdf11849"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"f6075515-d38f-4624-bde8-a1ce20473a69","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/f6075515-d38f-4624-bde8-a1ce20473a69"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"2023f974-a6eb-4226-931c-c458444b2d2b","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/2023f974-a6eb-4226-931c-c458444b2d2b"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/d5f42359-b2ad-4c68-9cbf-3337d4ffeae1","resource":{"resourceType":"MeasureReport","id":"d5f42359-b2ad-4c68-9cbf-3337d4ffeae1","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"6e781a79-52f7-47f7-8ec6-3dad2d7483ca-parameters","parameter":[{"name":"subject","valueString":"18139ed5-7f67-428b-a7b6-776f34c70f5d"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#6e781a79-52f7-47f7-8ec6-3dad2d7483ca-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Prostate Ca Diagnosis but does not meet first treatment. Meets tumor staging, PSA, and Gleason.  First treatment ends before MP. \n\n"}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/d5f42359-b2ad-4c68-9cbf-3337d4ffeae1"}}]}